{"issuance_frequency":"","notes_translated":{"fr":"Le Relevé des maladies transmissibles au Canada est une publication bilingue et libre d'accès revue par un comité de lecture portant sur la prévention et le contrôle des maladies infectieuses nouvelles et tenaces.\r\n","en":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases. \r\n"},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"unknown","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"03373d42-b28c-439b-9109-6d468a0d26d0","metadata_created":"2018-12-24T14:41:53.736307","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2020-09-25T14:47:27.149539","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2018-12-24","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Adultes","Vaccinations","Oreillons","Jeune","Adulte","Population","Streptococcus pneumoniae","Population marginalisée","VIH","Innocuité","Vaccin","Canada","Dépistage","Séronégatives","Groupes à risque"],"en":["Adult","Immunization","Mumps","Outbreak","Young","Adult","Population","Streptococcus pneumoniae","Marginalized population","Surveillance","HIV","Vaccine","Safety","Canada","Screening","Testing","HIV-negative","risk groups"]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"RMTC: Volume 44-12, le 6 décembre 2018 : L’immunisation des adultes","en":"CCDR: Volume 44-12, December 6, 2018: Adult immunization"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"03373d42-b28c-439b-9109-6d468a0d26d0","datastore_active":false,"character_set":"","size":0,"id":"e8045b3f-4494-47d9-889d-ce4e9a7125dd","state":"active","name_translated":{"fr":"\"RMTC: Volume 44-12, le 6 décembre 2018 : L’immunisation des adultes\"","en":"\"CCDR: Volume 44-12, December 6, 2018: Adult immunization\""},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"\"CCDR: Volume 44-12, December 6, 2018: Adult immunization\"","language":["en"],"created":"2018-12-24T14:41:54.343363","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2018-44/issue-12-december-6-2018.html","last_modified":null,"position":0,"revision_id":"0f62d56f-b4c1-4c5c-b355-cc1bbc4198e8","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"03373d42-b28c-439b-9109-6d468a0d26d0","datastore_active":false,"character_set":"","size":0,"id":"29ae2264-a6fd-4f51-84b1-59a4b4adb4f0","state":"active","name_translated":{"fr":"\"RMTC: Volume 44-12, le 6 décembre 2018 : L’immunisation des adultes\"","en":"\"CCDR: Volume 44-12, December 6, 2018: Adult immunization\""},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"\"CCDR: Volume 44-12, December 6, 2018: Adult immunization\"","language":["fr"],"created":"2018-12-24T14:41:54.343372","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2018-44/numero-12-6-decembre-2018.html","last_modified":null,"position":1,"revision_id":"2db58b39-52ed-418a-818d-9a078ebfd5b3","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"03373d42-b28c-439b-9109-6d468a0d26d0","datastore_active":false,"character_set":"","size":0,"related_type":"","state":"active","id":"5f378b83-6056-44f5-a9eb-b4b66457f6b2","related_relationship":"","name_translated":{"fr":"RMTC: Volume 44-12, le 6 décembre 2018 : L’immunisation des adultes","en":"CCDR: Volume 44-12, December 6, 2018: Adult immunization"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 44-12, December 6, 2018: Adult immunization","language":["en"],"created":"2018-12-24T14:41:54.343374","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2018-44/issue-12-december-6-2018/ccdrv44i12-eng.pdf","last_modified":null,"position":2,"revision_id":"54c9a7c7-bb5d-4970-9986-a3d4d080b717","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"03373d42-b28c-439b-9109-6d468a0d26d0","datastore_active":false,"character_set":"","size":0,"related_type":"","state":"active","id":"6ff53718-3bcb-44bb-b85b-d7f122d763dd","related_relationship":"","name_translated":{"fr":"\"RMTC: Volume 44-12, le 6 décembre 2018 : L’immunisation des adultes\"","en":"\"CCDR: Volume 44-12, December 6, 2018: Adult immunization\""},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"\"CCDR: Volume 44-12, December 6, 2018: Adult immunization\"","language":["fr"],"created":"2018-12-24T14:41:54.343377","url":"https://www.canada.ca/content/dam/phac-aspc/documents/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2018-44/issue-12-december-6-2018/ccdrv44i12f-fra.pdf","last_modified":null,"position":3,"revision_id":"72a4b35b-fb68-4f7c-ab1a-f7a4fc4e5930","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"03373d42-b28c-439b-9109-6d468a0d26d0","datastore_active":false,"character_set":"","size":22688,"related_type":"","state":"active","id":"a7d03234-46e8-4e89-8cad-9c074b0352b9","related_relationship":"","name_translated":{"fr":"Contrôle d'une éclosion d'oreillons chez une population de jeunes adultes","en":"Controlling a mumps outbreak in a young adult population"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Controlling a mumps outbreak in a young adult population","language":["en"],"created":"2018-12-24T14:41:54.343379","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2018-44/issue-12-december-6-2018/article-1-controlling-mumps-outbreak-young-adult-population.html","last_modified":null,"position":4,"revision_id":"088353df-4f2c-481a-84be-c8e3ce3382e3","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"03373d42-b28c-439b-9109-6d468a0d26d0","datastore_active":false,"character_set":"","size":0,"related_type":"","state":"active","id":"24b13d1d-ffa5-4a4b-b1ee-c78baf3f5107","related_relationship":"","name_translated":{"fr":"Contrôle d'une éclosion d'oreillons chez une population de jeunes adultes","en":"Controlling a mumps outbreak in a young adult population"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Controlling a mumps outbreak in a young adult population","language":["fr"],"created":"2018-12-24T14:41:54.343381","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2018-44/numero-12-6-decembre-2018/article-1-controle-eclosion-oreillons-population-jeunes-adultes.html","last_modified":null,"position":5,"revision_id":"2fa719ae-b3b5-456b-a12a-da406a780f98","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"03373d42-b28c-439b-9109-6d468a0d26d0","datastore_active":false,"character_set":"","size":0,"id":"82fe6a86-403c-4513-90e3-017c70f543fc","state":"active","name_translated":{"fr":"Éclosion d’une forme invasive de Streptococcus pneumoniae dans les quartiers défavorisés de Victoria, en Colombie-Britannique, de 2016 à 2017","en":"Challenges of an invasive Streptococcus pneumoniae outbreak in a marginalized population"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Challenges of an invasive Streptococcus pneumoniae outbreak in a marginalized population","language":["en"],"created":"2018-12-24T14:41:54.343384","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2018-44/issue-12-december-6-2018/article-2-challenges-invasive-streptococcus-pneumoniae-outbreak.html","last_modified":null,"position":6,"revision_id":"19a4f082-497a-44b2-a89b-2927d79e2351","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"03373d42-b28c-439b-9109-6d468a0d26d0","datastore_active":false,"character_set":"","size":0,"id":"c3bd9309-8a8d-4da8-a908-387d1088c068","state":"active","name_translated":{"fr":"Éclosion d’une forme invasive de Streptococcus pneumoniae dans les quartiers défavorisés de Victoria, en Colombie-Britannique, de 2016 à 2017","en":"Challenges of an invasive Streptococcus pneumoniae outbreak in a marginalized population"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Challenges of an invasive Streptococcus pneumoniae outbreak in a marginalized population","language":["fr"],"created":"2018-12-24T14:41:54.343386","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2018-44/numero-12-6-decembre-2018/article-2-defis-eclosion-streptocoque.html","last_modified":null,"position":7,"revision_id":"74835cb5-aaf2-4891-af2d-f755295197f7","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"03373d42-b28c-439b-9109-6d468a0d26d0","datastore_active":false,"character_set":"","size":0,"id":"2d741503-5297-41a7-965b-759a9f0f8e6a","state":"active","name_translated":{"fr":"Le VIH au Canada : Rapport de surveillance, 2017","en":"HIV in Canada—Surveillance Report, 2017"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"HIV in Canada—Surveillance Report, 2017","language":["en"],"created":"2018-12-24T14:41:54.343388","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2018-44/issue-12-december-6-2018/article-3-hiv-in-canada-2017.html","last_modified":null,"position":8,"revision_id":"238b8958-7ede-4b42-aef0-ce06c344b2ad","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"03373d42-b28c-439b-9109-6d468a0d26d0","datastore_active":false,"character_set":"","size":0,"id":"daf37c6e-4f50-4b0c-b5fc-4d9cec5e7633","state":"active","name_translated":{"fr":"Le VIH au Canada : Rapport de surveillance, 2017","en":"HIV in Canada—Surveillance Report, 2017"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"HIV in Canada—Surveillance Report, 2017","language":["fr"],"created":"2018-12-24T14:41:54.343390","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2018-44/numero-12-6-decembre-2018/article-3-le-vih-au-canada-2017.html","last_modified":null,"position":9,"revision_id":"df900751-092c-4f55-8849-e039da188882","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"03373d42-b28c-439b-9109-6d468a0d26d0","datastore_active":false,"character_set":"","size":0,"id":"203613a5-4361-4c43-9d88-882b012bf9f9","state":"active","name_translated":{"fr":"Surveillance de l’innocuité des vaccins au Canada : déclarations au SCSESSI, 2017","en":"Vaccine safety surveillance in Canada: Reports to CAEFISS, 2017"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Vaccine safety surveillance in Canada: Reports to CAEFISS, 2017","language":["en"],"created":"2018-12-24T14:41:54.343393","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2018-44/issue-12-december-6-2018/article-4-vaccine-safety-in-canada-2017.html","last_modified":null,"position":10,"revision_id":"3250fc28-6975-4190-9762-0eb495870834","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"03373d42-b28c-439b-9109-6d468a0d26d0","datastore_active":false,"character_set":"","size":0,"related_type":"","state":"active","id":"58a55194-81ef-45d1-831f-59714949e9f6","related_relationship":"","name_translated":{"fr":"Surveillance de l’innocuité des vaccins au Canada : déclarations au SCSESSI, 2017","en":"Vaccine safety surveillance in Canada: Reports to CAEFISS, 2017"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Vaccine safety surveillance in Canada: Reports to CAEFISS, 2017","language":["fr"],"created":"2018-12-24T14:41:54.343395","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2018-44/numero-12-6-decembre-2018/article-4-innocuite-vaccins-au-canada-2017.html","last_modified":null,"position":11,"revision_id":"6dc22303-f229-43c8-ba27-67475d7f06d1","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"03373d42-b28c-439b-9109-6d468a0d26d0","datastore_active":false,"character_set":"","size":0,"related_type":"","state":"active","id":"e1bd168d-d05c-4a9e-b4e4-b71d6341843f","related_relationship":"","name_translated":{"fr":"Données probantes portant sur l’optimisation de la fréquence des tests de dépistage du VIH chez des personnes séronégatives issues de divers groupes à risque : revue systématique","en":"Evidence for optimal HIV screening and testing intervals in HIV-negative individuals from various risk groups: A systematic review"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Evidence for optimal HIV screening and testing intervals in HIV-negative individuals from various risk groups: A systematic review","language":["en"],"created":"2018-12-24T14:41:54.343397","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2018-44/issue-12-december-6-2018/article-5-hiv-screening-testing-intervals-in-hiv-negative-individuals.html","last_modified":null,"position":12,"revision_id":"83e2a21c-006d-4d1b-bb5a-98b4602cf4ca","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"03373d42-b28c-439b-9109-6d468a0d26d0","datastore_active":false,"character_set":"","size":0,"id":"fc14aad9-603d-4062-ae3a-e1aaadcecca9","state":"active","name_translated":{"fr":"Données probantes portant sur l’optimisation de la fréquence des tests de dépistage du VIH chez des personnes séronégatives issues de divers groupes à risque : revue systématique","en":"Evidence for optimal HIV screening and testing intervals in HIV-negative individuals from various risk groups: A systematic review"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Evidence for optimal HIV screening and testing intervals in HIV-negative individuals from various risk groups: A systematic review","language":["fr"],"created":"2018-12-24T14:41:54.343399","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2018-44/numero-12-6-decembre-2018/article-5-vih-depistage-frequence-des-tests-persones-seronegatives.html","last_modified":null,"position":13,"revision_id":"d071a833-eab2-484e-8d61-008a4afb2c6b","resource_type":"website"}],"place_of_publication":[],"num_resources":14,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Agence de la santé publique du Canada","en":"Public Health Agency of Canada"},"date_published":"2018-06-18 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:57.068700","title":"Public Health Agency of Canada | Agence de la santé publique du Canada","name":"phac-aspc","is_organization":true,"state":"active","image_url":"","revision_id":"96161da6-edc7-4d1d-99e0-baac9df7b3b9","type":"organization","id":"1C71053B-AA64-4646-956B-41631C396018","approval_status":"approved"},"name":"03373d42-b28c-439b-9109-6d468a0d26d0","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases. \r\n","owner_org":"1C71053B-AA64-4646-956B-41631C396018","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"CCDR: Volume 44-12, December 6, 2018: Adult immunization","revision_id":"2c255b42-c81a-4c10-85a4-aa05272e0922"}